10-Q
Quarterly Report
OAKTREE ACQUISITION CORP. III LIFE SCIENCES OACC OACCU OACCW
0001193125-26-221814
- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$158.04K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$75.56K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.28M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.43M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$7.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$6.77M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$6.52M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$6.07M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.62M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.64M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.32M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.42M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.55M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $204.83M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $203.11M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.39M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.66M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$456.54K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$444.8K |